Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New device may let back surgery patients get moving sooner

NCT ID NCT07667348

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a special device placed during disc surgery can help people return to normal activities faster by preventing the disc from herniating again. About 120 adults with a herniated disc in the lower back will be randomly assigned to different post-surgery activity plans. The main goal is to see if the device reduces the chance of a repeat herniation.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
annular closure device (Barricaid)
What this could lead to
If successful, this could show that using an annular closure device lets people return to normal activities sooner after disc surgery with a lower risk of reherniation.
What could go wrong
This is a small, early-phase trial with only 120 people, so results may not apply to everyone. The device itself carries surgical risks like infection or device failure.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 4

Runs after approval, following long-term safety and how well the treatment works in everyday use.

Participants

About 120 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jun 2026

An estimate. Start dates often move.

Expected to finish

Oct 2027

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

Children (under 18), adults (18 to 64) and older adults (65 and over)

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Skeletally mature (male or female). * Patients with posterior or posterolateral disc herniations at one level between L4 and S1 with radiographic confirmation of neural compression using MRI. \[Note: Intraoperatively, only patients with an annular defect (post discectomy) between 4mm and 6mm tall and 6mm and 10mm wide shall qualify.\] * Minimum posterior disc height of 5mm at the index level. * Radiculopathy (with or without back pain) with a positive Straight Leg Raise (0 - 60 degrees)22 (L45, L5S1) * VAS leg pain (one or both legs) of at least 40/100 at baseline * Psychosocially, mentally and physically able to fully comply with the clinical protocol and willing to adhere to follow-up schedule and requirements. * Implanted with annular closure device. Exclusion Criteria: * Spondylolisthesis Grade II or higher (25% slip or greater). * Subject requires spinal surgery other than a discectomy (with or without laminotomy) to treat leg/back pain (scar tissue and osteophyte removal is allowed). * Subject has been diagnosed with active hepatitis, AIDS, or HIV. * Subject has been diagnosed with rheumatoid arthritis or other autoimmune disease. * Subject has a known allergy to titanium, polyethylene or polyester materials. * Any subject that cannot have a baseline MRI taken. * Subject is pregnant or interested in becoming pregnant in the next year. * Subject has active tuberculosis or has had tuberculosis in the past three (3) years. * Subject has a history of active malignancy: A patient with a history of any invasive malignancy (except non-melanoma skin cancer), unless he/she has been treated with curative intent and there have been no signs or symptoms of the malignancy for at least two (2) years. * Subject is immunologically suppressed, received steroids \>1 month over the past year. * Currently taking anticoagulants, other than aspirin, unless the patient can be taken off the anticoagulant for surgery. * Subject has a current chemical/alcohol dependency or significant psychosocial disturbance. * Subject has a life expectancy of less than three (3) years. * Subject is currently involved in active spinal litigation (Workers' compensation patients may be included. * Subject is currently involved in another investigational study. * Subject is incarcerated. * Subject has back or non-radicular leg pain of unknown etiology. * Prior surgery at the index lumbar vertebral level. * Subject requiring a spine DEXA (i.e., patients with SCORE of ≥ 6) with a T Score less than -2.0 at the index level. For patients with a herniation at L5/S1, the average T score of L1-L4 shall be used. * Subject has clinically compromised vertebral bodies in the lumbosacral region due to any traumatic, neoplastic, metabolic, or infectious pathology. * Subject has sustained pathologic fractures of the vertebra or multiple fractures of the vertebra or hip. * Subject has scoliosis of greater than ten (10) degrees (both angular and rotational). * Any metabolic bone disease. * Subject has an active infection either systemic or local. * Subject has cauda equina syndrome or neurogenic bowel/bladder dysfunction. * Subject has severe arterial insufficiency of the legs or other peripheral vascular disease. (Screening on physical examination for patients with diminution or absence of dorsalis pedis or posterior tibialis pulses. If diminished or absent by palpation, then an arterial ultrasound is required with vascular plethysmography. If the absolute arterial pressure is below 50mm of Hg at the calf or ankle level, then the patient is to be excluded.) * Subject has significant peripheral neuropathy, patient defined as a patient with Type I or Type II diabetes or similar systemic metabolic condition causing decreased sensation in a stocking-like or non-radicular and non-dermatomal distribution in the lower extremities. * Subject has insulin-dependent diabetes mellitus. * Subject is morbidly obese (defined as a body mass index \>40 or weighs more than 100 lbs. over ideal body weight).

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Disc herniation are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Intervertebral Disc Displacement lumbar disk herniation, susceptibility to

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Spine Institute of Louisiana

    Shreveport, Louisiana, 71101, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.